ArticleSignal transduction and targeted therapy2024

The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.

Qiaonan Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.